Nefopam D3

Modify Date: 2024-01-10 10:41:21

Nefopam D3 structure	Common Name	Nefopam D3
	CAS Number	1346747-15-6	Molecular Weight	256.36
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₇H₁₆D₃NO	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Nefopam D3

Nefopam D3 (Fenazoxine D3) is a deuterium labeled Nefopam (Fenazoxine). Nefopam is a centrally-acting but non-opioid analgesic drug, and Nefopam targets β-catenin protein level in mesenchymal cells[1][2].

Name	Nefopam D3

Description	Nefopam D3 (Fenazoxine D3) is a deuterium labeled Nefopam (Fenazoxine). Nefopam is a centrally-acting but non-opioid analgesic drug, and Nefopam targets β-catenin protein level in mesenchymal cells[1][2].
Related Catalog	Research Areas >> Neurological Disease
References	[1]. Kim KH, et al. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain. 2014 Apr;27(2):103-11. [2]. Baht GS, et al. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair. Bone. 2017 May;98:31-36. [3]. Poon R, et al. A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders. PLoS One. 2012;7(5):e37940.

Description

Related Catalog

Research Areas >> Neurological Disease

References

[1]. Kim KH, et al. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain. 2014 Apr;27(2):103-11.

[2]. Baht GS, et al. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair. Bone. 2017 May;98:31-36.

[3]. Poon R, et al. A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders. PLoS One. 2012;7(5):e37940.

Molecular Formula	C₁₇H₁₆D₃NO
Molecular Weight	256.36

Nefopam D3

Use of Nefopam D3

Names

Nefopam D3 Biological Activity

Chemical & Physical Properties